cytarabine has been researched along with Chronic Illness in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (31.25) | 18.7374 |
| 1990's | 5 (15.63) | 18.2507 |
| 2000's | 8 (25.00) | 29.6817 |
| 2010's | 6 (18.75) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, S; Burnett, AK; Cahalin, P; Clark, RE; Hills, RK; Kjeldsen, L; Russell, NH; Thomas, IF | 1 |
| Haboosheh, A; Lossos, A; Mikhelashvili, L; Vainstein, V | 1 |
| Cheng, B; Du, J; Fu, MH; Pan, YY; Tao, XF | 1 |
| Fan, B; Ge, J; Ge, L; Lu, H; Ma, J; Qian, J; Zhong, X | 1 |
| Ansai, SI; Hoashi, T; Ichiyama, S; Kanda, N; Komatsu, T; Nagai, K; Saeki, H; Yamada, Y | 1 |
| Al-Malki, H; Cebrian-Silla, A; Fehse, B; Fransen, NL; Garcia-Verdugo, JM; Gomez-Nicola, D; Perry, VH; Riecken, K; Suzzi, S; Vargas-Caballero, M | 1 |
| Croxson, G; Halmagyi, GM; McCluskey, P; O'Connor, L | 1 |
| Caballero, D; Canales, M; Dlouhy, I; González-Barca, E; López-Guillermo, A; Martín, A; Montes-Moreno, S; Ocio, EM; Redondo, AM; Salar, A | 1 |
| Ding, J; Jing, Y; Wang, HX; Wang, LJ; Yang, H; Yu, L; Zhu, CY | 1 |
| Borrego, L; Guillermo, N; Hernández-Machín, B; Montenegro, T; Peñate, Y | 1 |
| Beth Rios, M; Cortes, J; Faderl, S; Ferrajoli, A; Garcia-Manero, G; Giles, FJ; Kantarjian, HM; O'Brien, S; Shan, J; Talpaz, M; Thomas, D; Verstovsek, S; Wierda, W | 1 |
| Abboud, CN; Bennett, JM; Dewald, G; Friedenberg, W; Hayes, FA; Liesveld, JL; Makary, AZ; Neuberg, D; Paietta, E; Rowe, JM; Tallman, MS; Wiernik, PH | 1 |
| Abe, Y; Choi, I; Inaba, S; Matsushima, T; Muta, K; Nagasawa, E; Nawata, H; Nishimura, J; Ohtsuka, R; Tachikawa, Y | 1 |
| Bogdahn, U; Hans, VH; Hau, P; Kleiter, I; Marienhagen, J; Schuierer, G; Schütz, H; Steinbrecher, A | 1 |
| Bernard, F; Bertrand, Y; Chastagner, P; Colin, VM; Donadieu, J; Landman Parker, J; Munzer, M; Ouache, M; Perel, Y; Thomas, C; Vermylen, C | 1 |
| Hamaguchi, M; Hirabayashi, N; Iida, H; Inamoto, Y; Iseki, T; Kami, M; Kodera, Y; Maruyama, F; Miyamura, K; Morishima, Y; Morishita, Y; Naoe, T; Nishida, T; Sao, H; Suzuki, R; Takeyama, H; Yano, K | 1 |
| Spaeth, GL | 1 |
| Breithaupt, H; Przuntek, H | 1 |
| Gordon, M | 1 |
| Kaya, H; Kobayashi, K; Matano, S; Nakamura, S; Sugimoto, T; Yoshida, T | 1 |
| Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC | 1 |
| Asano, S; Kikuchi, A; Nishikawa, T; Okamoto, S; Takahashi, S | 1 |
| Chen, X; Greinix, HT; Haas, OA; Kalhs, P; Keil, F; Lechner, K; Loidolt, H; Louda, N; Mannhalter, C; Mitterbauer, G; Moser, K; Pirc-Danoewinata, H; Rabitsch, W; Worel, N | 1 |
| Asherov, J; Pinkhas, J; Shoenfeld, Y | 1 |
| Kuntz, HD | 1 |
| Higby, DJ; Rustum, YM | 1 |
| Kent, S | 1 |
| Chomel, B; Fourel, I; Fox, JJ; Hantz, O; Jacquet, C; Trepo, C; Watanabe, KA | 1 |
| Fernandez, LA; Zayed, E | 1 |
| Hammerstrøm, J; Lamvik, J; Waage, A | 1 |
| Bauer, DJ | 1 |
| Hunstein, W | 1 |
2 review(s) available for cytarabine and Chronic Illness
| Article | Year |
|---|---|
Antiviral chemotherapy: the first decade.
Topics: Acute Disease; Amantadine; Antiviral Agents; Chickenpox; Chronic Disease; Cytarabine; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Influenza, Human; Molluscum Contagiosum; Semicarbazones; Smallpox; Vaccinia; Warts | 1973 |
[Therapeutic considerations in chronic myeloid leukemia].
Topics: Busulfan; Chronic Disease; Cytarabine; Humans; Hydrocarbons, Brominated; Leukemia, Myeloid; Mannitol | 1974 |
4 trial(s) available for cytarabine and Chronic Illness
| Article | Year |
|---|---|
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Clofarabine; Cytarabine; Daunorubicin; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; United Kingdom; Vidarabine | 2022 |
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Treatment Outcome; Young Adult | 2016 |
Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cytarabine; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome | 2003 |
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chronic Disease; Cytarabine; Cytogenetics; Disease-Free Survival; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Middle Aged; Recombinant Proteins; Survival Analysis; Time Factors | 2004 |
26 other study(ies) available for cytarabine and Chronic Illness
| Article | Year |
|---|---|
Intrathecal cytosine arabinoside-induced progression of chronic methotrexate myelopathy.
Topics: Chronic Disease; Cytarabine; Humans; Injections, Spinal; Methotrexate; Spinal Cord Diseases | 2021 |
Safety and efficacy of a low frame rate protocol for percutaneous coronary intervention for chronic total occlusions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Coronary Angiography; Coronary Occlusion; Cytarabine; Daunorubicin; Humans; Percutaneous Coronary Intervention; Podophyllotoxin; Thioguanine; Treatment Outcome | 2021 |
Safety and feasibility of a low frame rate protocol for percutaneous coronary intervention to chronic total occlusions: preliminary experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Coronary Angiography; Coronary Occlusion; Cytarabine; Daunorubicin; Feasibility Studies; Humans; Percutaneous Coronary Intervention; Podophyllotoxin; Registries; Thioguanine; Treatment Outcome | 2018 |
Treatment with apremilast was beneficial for chronic graft-versus-host disease skin lesion in a patient with psoriasis.
Topics: Administration, Oral; Biopsy; Bone Marrow Transplantation; Chronic Disease; Cytarabine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Psoriasis; Skin; Thalidomide; Transplantation, Homologous; Treatment Outcome | 2019 |
Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration.
Topics: Adult; Aged; Alzheimer Disease; Animals; Antimetabolites, Antineoplastic; Cell Proliferation; Chronic Disease; Creutzfeldt-Jakob Syndrome; Cytarabine; Dentate Gyrus; Disease Models, Animal; Disease Progression; Female; Genetic Vectors; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Mossy Fibers, Hippocampal; Neural Pathways; Neural Stem Cells; Neuroanatomical Tract-Tracing Techniques; Neurodegenerative Diseases; Neurogenesis; Patch-Clamp Techniques; Prion Diseases; Prions; Time Factors; Tissue Banks; Young Adult | 2014 |
A 43-year-old woman presenting with subacute, bilateral, sequential facial nerve palsies, then developing pseudotumour cerebri.
Topics: Adult; Anticoagulants; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bell Palsy; Chemoradiotherapy; Chronic Disease; Cyclophosphamide; Cytarabine; Delayed Diagnosis; Dexamethasone; Doxorubicin; Female; Humans; Intracranial Hypertension; Lymphoma, B-Cell; Magnetic Resonance Imaging; Mastoid; Methotrexate; Optic Atrophy; Otitis Media, Suppurative; Papilledema; Pseudotumor Cerebri; Sinus Thrombosis, Intracranial; Treatment Outcome; Vincristine; Vision, Low | 2015 |
[Clinic Outcome of FLAG Regimen treating Patients with Refractory and Relapse Acute Myeloid Leukemia].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Recurrence; Remission Induction; Survival Rate; Treatment Outcome; Vidarabine; Young Adult | 2016 |
Cytarabine-associated lymphoid dyscrasia with atypical T CD30+ infiltrate in a patient suffering from acute nonlymphoblastic leukaemia.
Topics: Chronic Disease; Cytarabine; Female; Humans; Immunosuppressive Agents; Ki-1 Antigen; Leukemia, Myeloid, Acute; Middle Aged; Skin Diseases | 2009 |
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Combined Modality Therapy; Cyclosporine; Cytarabine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pneumonia; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2004 |
Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis.
Topics: Adult; Chronic Disease; Cytarabine; Disease Progression; Dura Mater; Headache; Humans; Hypertrophy; Immunosuppressive Agents; Inflammation; Injections, Intraventricular; Male; Meningitis; Treatment Outcome | 2004 |
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cladribine; Cytarabine; Drug Therapy, Combination; Female; Hematologic Diseases; Histiocytosis, Langerhans-Cell; Humans; Infant; Infusions, Intravenous; Male; Pilot Projects; Survival Analysis | 2005 |
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Chronic Disease; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2007 |
Chronic membranous conjunctivitis. A persisting problem.
Topics: Adrenal Cortex Hormones; Child; Chronic Disease; Conjunctivitis; Cytarabine; Drug Synergism; Humans; Idoxuridine; Male | 1967 |
Cytarabine: distribution in ventricular cerebrospinal fluid after lumbar injection.
Topics: Cerebral Ventricles; Chronic Disease; Cytarabine; Humans; Injections, Spinal; Lumbosacral Region; Male; Meningitis; Middle Aged; Tissue Distribution | 1981 |
Severe toxicity of fialuridine (FIAU)
Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Cytarabine; Drug Approval; Hepatitis B; Humans | 1996 |
[Low-dose combination cytarabine and etoposide for myeloid crisis transformed from unclassified chronic myeloproliferative disorder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Chronic Disease; Cytarabine; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Myeloproliferative Disorders | 1996 |
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1996 |
Linear chronic cutaneous graft-versus-host disease.
Topics: Adult; Basement Membrane; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Cytarabine; E-Selectin; Epidermis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Keratosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Methotrexate; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Homologous; Whole-Body Irradiation | 1997 |
PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR.
Topics: Adult; Cell Nucleus; Chronic Disease; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Interphase; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Oncogene Proteins; Polymerase Chain Reaction; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-bcr | 2001 |
Bone pains in chronic myelomonocytic leukaemia, treated by cytosine arabinoside.
Topics: Bone Diseases; Chronic Disease; Cytarabine; Humans; Leukemia, Myeloid; Pain | 1978 |
[Monocytic leukemia. Analysis of clinical and hematological data in 21 patients (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Examination; Chronic Disease; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Monocytes; Sternum; Vincristine | 1977 |
Biochemical and clinical studies of chronic lymphocytic leukemia.
Topics: Aged; Animals; Chronic Disease; Cytarabine; DNA, Neoplasm; Humans; In Vitro Techniques; Leukemia, Lymphoid; Male; Mercaptopurine; Mice; Middle Aged; Neoplasms, Experimental; Ribonucleotides; RNA, Neoplasm | 1978 |
Continuous drug delivery methods reflect progress in therapy for chronic diseases.
Topics: Aged; Chronic Disease; Cytarabine; Dosage Forms; Drug Implants; Glaucoma; Humans; Injections, Intravenous; Leukemia; Levodopa; Neoplasms; Parkinson Disease; Pilocarpine; Research | 1977 |
Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks.
Topics: Administration, Oral; Animals; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Cytarabine; Hepadnaviridae; Hepatitis, Viral, Animal; Uridine; Virus Replication | 1990 |
Busulfan-induced sideroblastic anemia.
Topics: Anemia, Sideroblastic; Bone Marrow; Busulfan; Chronic Disease; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Leukocyte Count; Middle Aged; Pancytopenia | 1988 |
Chronic granulocytic leukaemia in accelerated stage treated with low dose cytosine arabinoside.
Topics: Chronic Disease; Cytarabine; Humans; Leukemia, Myeloid; Male; Middle Aged | 1985 |